Eflornithine Maintenance After Consolidation Immunotherapy in Patients With High-Risk Neuroblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons
J. Clin. Oncol 2023 Oct 26;[EPub Ahead of Print], J Oesterheld, W Ferguson, JM Kraveka, G Bergendahl, T Clinch, E Lorenzi, D Berry, RK Wada, MS Isakoff, DE Eslin, VI Brown, W Roberts, P Zage, VL Harrod, DS Mitchell, D Hanson, GL Saulnier ShollerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.